Peroxisome proliferator-activated receptors as molecular targets in relation to obesity and Type 2 diabetes

By ŠŠeda Ondøøřřej   ŠŠedováá Lucie  

Pharmacogenomics, Vol. 8, Iss. 6, 2007-06 ,pp. : 587-596

Future Medicine

Access to resources Recommend Favorite

Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury

By Esposito Emanuela   Cuzzocrea Salvatore  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 8, 2011-08 ,pp. : 943-959

Informa Healthcare

Access to resources Recommend Favorite

Macrophage peroxisome proliferator activated receptor γ as a therapeutic target to combat Type 2 diabetes

By Pascual Gabriel   Ricote Mercedes   Hevener Andrea L  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 11, 2007-11 ,pp. : 1503-1520

Informa Healthcare

Access to resources Recommend Favorite

Physiological Role of Peroxisome Proliferator-Activated Receptors Type Alpha on Dopamine Systems

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 1, 2013-02 ,pp. : 70-77

Bentham Science Publishers

Access to resources Recommend Favorite

Novel peroxisome proliferator-activated receptor ligands for Type 2 diabetes and the metabolic syndrome

By Miller Anne R   Etgen Garret J  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1489-1500

Informa Healthcare

Access to resources Recommend Favorite